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BACKGROUND: Between 1966 and 1974, France conducted 41 atmospheric nuclear tests in Polynesia, but their potential health effects
have not previously been investigated.
METHODS: In a case–control study, we compared the radiation exposure of almost all the French Polynesians diagnosed with
differentiated thyroid carcinoma between 1981 and 2003 (n¼229) to the exposure of 373 French Polynesian control individuals
without cancer from the general population. Radiation exposures were estimated using measurements after the nuclear tests, age at
time of each test, residential and dietary information.
RESULTS: The average thyroid dose before 15 years of age was about 1.8mGy, and 5% of the cases and 3% of the controls received a
dose above 10mGy. Despite this low level of dose, and after adjusting for ethnic group, level of education, body surface area, family
history of thyroid cancer and number of pregnancies for women, we observed an increasing risk (P¼0.04) of thyroid cancer
with increasing thyroid dose received before age of 15 years, which remained after excluding non-aggressive differentiated thyroid
micro-carcinomas. This increase of risk per unit of thyroid radiation dose was higher (P¼0.03) in women who later experienced four
or more pregnancies than among other women.
CONCLUSION: The risk estimate is low, but is based on limited exposure data. The release of information on exposure, currently
classified, would greatly improve the reliability of the risk estimation.
British Journal of Cancer (2010) 103, 1115–1121. doi:10.1038/sj.bjc.6605862 www.bjcancer.com
Published online 31 August 2010
& 2010 Cancer Research UK
Keywords: differentiated thyroid carcinoma; nuclear test; French Polynesia; radiation-induced cancer
                                                         
Between 1945 and 1980, the United States, the Soviet Union, the
United Kingdom, France and China carried out 520 atmospheric
tests of nuclear weapons totalling the explosive equivalent of
440 megatons (Boice, 2006). After a nuclear explosion, radioactive
debris is initially swept upwards and then dispersed in the
directions of the prevailing winds. Local deposition of radio-
nuclides fallout from radioactive clouds can expose populations to
external and internal irradiation. External irradiation exposure is
mainly from penetrating g-rays emitted by particles on the ground,
whereas the main source of internal irradiation is consumption of
contaminated food and water.
Between 1966 and 1974, France conducted 41 atmospheric
nuclear weapon tests in French Polynesia (FP) (Martin, 2007). This
consists of four archipelagos: Socie ´te ´, Marquises, Australes and
Tuamotu-Gambier, and 121 atolls or islands covering 4000km
2 of
land spread over 4 millions km
2 of the Pacific Ocean (Figure 1).
Tests took place in Mururoa and Fangataufa, in the southeastern
part of the Tuamotu-Gambier archipelago.
To evaluate the potential function of atmospheric nuclear tests
fallout in a high incidence of thyroid cancer observed in FP (de
Vathaire et al, 2000), a population-based case–control study of
thyroid cancer was performed. We have shown previously that a
high level of education (Brindel et al, 2008), tallness (Brindel et al,
2009), a high body mass index (Brindel et al, 2009), a family
history of thyroid cancer (Brindel et al, 2010) and, in women, a
large number of pregnancies (Brindel et al, 2010) were associated
with an increased risk of thyroid cancer in this population.
MATERIALS AND METHODS
In 1979, the South Pacific Commission recommended the creation
of a cancer registry in FP (Henderson et al, 1982). In 1980–1984,
two partial registries were in operation, maintained, respectively,
by clinicians and by pathologists. The cancer incidence registry of
FP was officially created in 1984 (Laudon, 1989). In 1996–1998, we
verified and completed the registry data on the basis of all the
medical evacuation files, insurance records and hospital and
pathological laboratory files available in FP. We also wrote to the
hospitals in France, New Zealand and Hawaii, where patients had
been evacuated from FP, asking for their list of patients from
Polynesia, and for a confirmation of cancer diagnosis. A total of
30000 records were examined, and 539 cancers diagnosed after
1984 among patients born and living in FP, which had not been
included in the cancer registry of FP, were identified during this
period (de Vathaire et al, 2000). An additional survey, limited to
thyroid cancer was also performed in 2002–2005, in order to
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ycomplete registry data with incident cases diagnosed up to 2002 in
data from medical insurance files, and records from the four
endocrinologists in Tahiti.
All patients diagnosed in 1981–2003 with thyroid cancer at the
age of 55 years or less, born and resident in FP at time of diagnosis,
were eligible. Four patients aged from 56 to 62 years at diagnosis,
one case diagnosed in 1979 and two in 2004, were included by
error and were kept in the analysis. Incomplete histological
information was completed from the two histopathology labora-
tories in Tahiti and from the medical files of endocrinologists.
Of the 255 eligible thyroid cancer cases, 26 (10%) were not
interviewed because they had died (n¼14), could not be located
(n¼6), refused to participate (n¼5) or were too ill to be
interviewed (n¼1). The final study population consisted of 229
cases (95% of the living potential cases).
For each eligible case, the two controls nearest in terms of date
of birth (þ/ 3 months for the first interviewed controls, changed
in þ/ 20 days afterwards) and matched on sex were identified
from the French Polynesian birth registry. Among 458 eligible
controls, 85 were not interviewed: 9 had died, 29 could not be
located, 29 refused to participate, 2 were too ill to be interviewed
and 16 had left FP. A total of 373 controls (83% of the alive
potential controls) were interviewed. At the end of the interviews,
169 cases had 2, 35 cases had 1 and 25 cases had no interviewed
controls. Each of these 25 cases was matched to a control initially
matched to another case, of the same sex and a close date of birth,
who had two interviewed controls; the control reassigned to the
case with no controls, and then not used for the originally matched
case. Matching on birth date was relaxed if necessary. Finally, of
the 229 interviewed cases, 85 were matched to one (37%) and 144
with two controls (63%). The difference in date of birth between a
case and his/her control(s) was o20 days for 270 controls, and
21–90 days for 88 controls and between 91 days and 21 months for
15 controls.
Cases and controls were interviewed face to face on ethnic
group, education, occupation, places of residence, weight history,
personal and familial history of thyroid disease and cancer,
gynaecologic and reproductive history, medical X-ray exposure
and diet at the time of the interview and during childhood. The
exposure of each case and his/her matched controls was taken into
account up to the age at diagnosis of the case.
Of the cases, 89% were women and 68.5% were under age
15 years in 1966 or born during the tests, that is potentially
exposed during childhood; 26.6% were aged 15 years or over in
1966 and 4.8% were born in 1975 or later, that is never exposed
(Table 1). Thyroid micro-carcinomas discovery depends on
clinical investigations, which may have been more intense in the
exposed population; a sensitivity analysis was, therefore, planned
for, excluding cases with unifocal tumours of 10mm or less or of
unknown size and without extra-thyroidal invasion.
The deposition densities of radionuclides on each island where
one study subject resided at the time of each test were
reconstructed on the basis of measurements of the radioactivity,
on information on the source of drinking water and on
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Figure 1 Map of French Polynesia, the symbol indicates the two nuclear test sites.
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ymeteorological information. This was performed using measure-
ments of total radioactivity in filtered air, of
131I and
137Cs in fresh
milk and of total g-activity and
137Cs in vegetables and fish
(Drozdovitch et al, 2008). Estimation of the water level in cisterns
before each test, size of the cisterns and information on wind and
rain were also used. For each study subject, the total thyroid dose
was the sum of the thyroid doses reconstructed for each test,
taking into account age, source of drinking water and data
collected in the diet questionnaire (Drozdovitch et al, 2008). The
individual consumption of each foodstuff at a given age was
deduced from the information on consumption during childhood
obtained in the interview, using age-specific scaling factors. Dose
reconstruction was conducted without knowledge of the case or
control status of the subject.
Statistical analysis
Data were analysed using conditional logistic regression (Breslow
and Day, 1987) with the Epicure epidemiological software (Preston
et al, 1993) and SAS V8.1. To investigate the relationship between
the thyroid radiation dose and the risk of thyroid cancer, we
compared nested models, using likelihood-ratio tests (Moolgavkar
and Venzon, 1987). Tests for linear trend (Breslow and Day, 1987)
were also performed. All analyses were adjusted for ethnic group:
Polynesian vs mixed origin (54% of cases and 55% of controls were
Polynesian), because Maoris are at higher risk of thyroid cancer
than others in FP. The analysis of the effect of radiation on the risk
of thyroid cancer was systematically adjusted for level of
education, height, body mass index, familial history of thyroid
cancer and number of pregnancies. The analysis was also adjusted
for the interviewer. All significance tests are two sided.
RESULTS
The average lifetime thyroid dose from exposure to radioactive
fallout was 2.6mGy both for cases and for controls with ranges
0–39mGy for the cases and 0–36mGy for the controls. Most of
the dose was received before age 15 years. Before 15 years, the
average doses received by the cases and by the controls were
1.8 and 1.7mGy, respectively, with ranges 0–38 and 0–36. The
73 cases who had received 41mGy to the thyroid had received an
average of 5.4mGy, whereas the 123 controls had received an
average of 4.7mGy. A dose of 10mGy or more was received by
5.2% of the cases and 3.2% of the controls. Table 2 describes the
characteristics of thyroid radiation exposure in terms of year and
site of residence, source and type of radionuclide. For both cases
and controls, most of the total thyroid doses resulted from
exposures in 1974, in the population residing in Tahiti or Moorea,
and the most important source of exposure was leafy vegetables.
Intake of
131I contributed to 75% and 78% of the mean thyroid
dose received before age 15 years, respectively, by the cases and
the controls.
The risk of thyroid cancer was found to increase significantly
with the thyroid dose received before age 15 years (P-value for
trend 0.04); this result was persisting when micro-carcinomas and
tumours of unknown size were excluded (P for trend 0.02; Table 3).
The excess relative risk per Gray (ERR/Gy) estimated by a linear
model was 55 (95% confidence interval (CI):  14 to 288). Ten
cases (9 men and 1 woman) and 12 controls (12 men) had worked
Table 1 Description of thyroid cancer cases, French Polynesia
Cases (N¼229)
Characteristics N %
Sex
Men 26 11.4
Women 203 88.6
Age at time of first test (years)
15+ 61 26.6
0–14 124 54.1
Born during tests 33 14.4
Born after tests 11 4.8
Age at diagnosis (years)
10–19 8 3.5
20–29 39 17.0
30–39 76 33.2
40–49 63 27.5
50–62 43 18.8
Histology
Papillary 176 76.9
Follicular 53 23.1
Tumour size (mm)
p10 106 52.2
11–40 75 36.9
440 22 10.8
Unknown 26 —
Multifocal tumour
No 128 61.0
Yes 82 39.0
Unknown 19 —
Extra-thyroidal invasion
No 191 83.4
Yes 38 16.6
Table 2 Characteristics of the thyroid dose received before age 15 years
Characteristic
Thyroid cancer
cases (229) (%)
Controls
(373) (%)
Year of exposure
1966 15 10
1967 2 2
1968 6 7
1969 0 0
1970 3 4
1971 8 7
1972 1 1
1973 7 7
1974 58 62
Island or archipelago of residence
Tahiti and Moorea 69 84
Other Socie ´te ´ islands 11 7
Australes 2 1
Marquises 3 3
Tuamotu-Gambier 15 5
Source
Leafy vegetables 74 71
Milk 11 14
Inhalation 6 4
Cistern rain water 3 5
Other foodstuffs 1 2
External irradiation 5 4
Radionuclides
131I7 5 7 8
132I,
133I,
135I,
132Te 18 16
137Cs 2 2
External irradiation 5 4
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cancer risk (Table 3).
We found a significant interaction (P¼0.03) between the effects
of the radiation dose and the number of pregnancies, both being
considered as continuous variables. The increase in risk with the
dose was greater among women who had four pregnancies or more
than among women with less than four pregnancies (Table 4),
which was also observed when thyroid micro-carcinomas and
cancers of unknown size were excluded (P-value for interaction
o0.01).
DISCUSSION
Given the geographic isolation of FP and the high standard of the
local public health system, it seems unlikely that many cases could
have escaped detection by all our sources of information. Thyroid
cancer being rarely lethal, the restriction of the study to cases alive
at the time of interview is not likely to have been a major source of
bias. The French Polynesian population was not aware of the
geographic distribution of the fallout during the 1966–1974
period. They were also unaware of the fact that leafy vegetables
were the most contaminated foodstuff, that drinking rain water
was a source of exposure and that fish consumption was not. The
declared consumption of each subject is, therefore, unlikely to be
biased by his/her status of case or control.
Controls were selected randomly from the Polynesian registry of
birth, which includes all persons born in FP. Among the 458
potential controls, 85 may not be interviewed, who were born
earlier than the interviewed controls (1955 in average, vs 1957,
P¼0.09), but of similar gender and place of birth distribution. As
analysis was performed using conditional logistic regression,
matched on birth date, this potential source of bias was controlled.
Matching on age was not as close as originally planned, but
exclusion of the 25 strata corresponding to the reassigned controls
and their cases did not modify the results, the OR for thyroid doses
of 10–19 and 20mSv or more, being, respectively, 5.6 and 3.3,
instead of 5.7 and 3.3 (Table 3).
Our thyroid dose estimates are similar to those estimated by the
French Army in 1977 and 1997 on the basis of the same
measurements (Bourge `s, 1998). The small number of available
measures for dose reconstruction probably led us to underestimate
the geographical variability in radioactive deposits and thus in
thyroid doses. This is more likely to have introduced uncertainties
and decreased power of our study than to have introduced a bias.
A thorough compilation of the results of all radiological
monitoring that have been carried out in FP in 1966–1974 would
greatly improve the reliability and the precision of the dose
estimates. Recently, the French Army has published new estima-
tions of the radiation dose to thyroid for the six tests, which led to
the highest fallout (Jurien de la Gravie `re, 2006). Those estimations
are higher than those reported in 1998 (Bourge `s, 1998), but we
were not able to use them because they do not take into account
the variability in food consumption and they exist only for six
islands or atolls.
We observed an ERR/Gy of 55 (95% CI:  14 to 288) for thyroid
cancers occurring about 25 years on average after
131I exposure.
Other nuclear test sites have been studied, mainly those from the
United States and Soviet Union. The United States performed
66 nuclear tests between 1946 and 1958 on Bikini and Enewetak
atolls in the Marshall Islands, resulting in radioactive fallout
contamination of a number of neighbourhood atolls. Estimated
thyroid doses were very high in some atolls: 6800mGy for 1-year-
old infants at the time of the Bravo nuclear test of 1954 at Utirik,
Table 3 Thyroid cancer risk according to dose before age 15 years and to work at nuclear sites
Total population
(229 cases and 373 controls)
Excluding unifocal micro-carcinomas, cancers of
unknown size and their controls (141 cases/231 controls)
Exposure Cases/controls
OR
(95% CI)
a
P-value
for trend Cases/controls
OR
(95% CI)
a
P-value
for trend
Thyroid dose before age 15 years
o1mGy 156/250 1
b 93/149 1
b
1–9.9mGy 61/111 1.0 (0.5–1.9) 0.04 39/74 1.1 (0.5–2.6) 0.02
10–19.9mGy 7/9 3.3 (0.8–14) 5/6 6.2 (0.9–41)
20–39mGy 5/3 5.7 (0.8–45) 4/2 11.6 (1.0–132)
Work at nuclear sites during tests
No 219/361 1
b 132/222 1
b
Yes 10/12 1.0 (0.3–3.5) 0.9 9/9 1.5 (0.4–5.8) 0.7
Abbreviations: OR¼odds ratio, CI¼confidence interval.
aAdjusted on ethnic group, level of education, body surface area, family history of thyroid cancer and number
of pregnancies for women.
bReference category.
Table 4 Risk of thyroid cancer in women according to radiation dose to the thyroid before age 15 years and to the number of pregnancies
Four pregnancies or more
(117 cases and 143 controls)
Less than four pregnancies
(86 cases and 183 controls)
Cases/controls OR
a (95% CI) P-value Cases/controls OR
a (95% CI) P-value
Thyroid radiation dose before age 15 years
o1mGy 83/115 1
b — 54/102 1
b —
1–9.9mGy 28/26 1.5 (0.6–3.7) 27/77 0.7 (0.3–1.5)
10mGy or more 6/2 11.2 (1.1–112) 5/9 2.2 (0.4–12)
Per mGy to the thyroid 1.07 (0.99–1.15) 0.07 0.96 (0.87–1.07) 0.4
Abbreviations: OR¼odds ratio, CI¼confidence interval.
aAdjusted on ethnic group, level of education, height, body mass index, menopausal status at time of cancer diagnosis
and familial history of thyroid cancer.
bReference category. P-value for interaction between the number of pregnancies (as a continuous variable) and the radiation dose: P¼0.03.
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yhalf of this dose at Ailuk and Mejit and 2% of this dose, that is still
120mGy, in the most distant atolls such as Majuro (Simon and
Graham, 1997). In 1993–97, a thyroid screening was performed in
about 60% of the living potentially exposed population. Thyroid-
nodules prevalence was found to be frequent and to be linked to
iodine intake rather than to external radiation exposure (Takaha-
shi et al, 1999). On the basis of a total of 57 cases (30 prevalent
screened cases þ27 previously diagnosed cases), there was a
suggestion (P¼0.15) of a relationship between thyroid dose and
thyroid cancer (Takahashi et al, 2003).
In a cohort of 2497 subjects having lived near the Nevada site
during the 90 atmospheric US nuclear tests and having received an
average radiation dose of 120mGy, eight thyroid cancers were
observed, too few for a dose response analysis, but the ERR/Gy for
all thyroid neoplasms was 13.0 (95% CI: 2.7–68.7) (Lyon et al,
2006). On the other hand, an ecological analysis of thyroid cancer
incidence rate, based on SEER data, estimated the ERR/Gy to be 2.4
(95% CI:  0.5 to 5.6) for the dose received before age of 1 year, but
no increase for that received afterwards (Gilbert et al, 2010).
In several villages near the nuclear test site of Semipalatinsk in
Kazakhstan, where the Soviet Union performed 116 atmospheric
tests in 1949–1962, the cumulative average total radiation dose to
the thyroid was 41Gy (Stepanenko et al, 2006). Thyroid disease
prevalence among 2994 residents of eight villages was ascertained
by ultrasound screening. Prevalence of papillary cancer (n¼26)
was low and not significantly associated with radiation dose (Land
et al, 2008). Thyroid-nodule prevalence (165 cases among 894
residents) was found to be 1.4 times (95% CI: 1.1–1.9) higher in
Ozyorsk near the Mayak nuclear weapons facility in Russia, than in
non-exposed populations, but only eight thyroid neoplasms have
been observed so far, despite thyroid doses, which could reach
several Grays (Mushkacheva et al, 2006). From 1944 through 1957,
approximately 2.73 10
16 Bq of
131I were released from the
Hanford Site in Washington State into the atmosphere, leading to
cumulative thyroid doses reaching several Grays (Shipler et al,
1996). In 1992–1997, 3440 individuals were screened for thyroid
pathology and their thyroid doses estimated (median, 97mGy;
mean, 174mGy). A total of 249 subjects were diagnosed with
benign thyroid nodules, the prevalence not varying with estimated
dose. Only 19 thyroid cancers were observed (Davis et al, 2004).
Although, in all these studies, estimated radiation doses were
much higher than in our study, reaching levels of one or several
Grays, their results are very variable. The small numbers of thyroid
cancers may explain the lack of a significant function of thyroid
radiation in certain studies (Khokhryakov et al, 2002; Takahashi
et al, 2003; Davis et al, 2004; Lyon et al, 2006; Mushkacheva et al,
2006). This finds support in the fact that, with the exception of
Marshall Islands (Takahashi et al, 2003) and Hanford studies
(Davis et al, 2004), thyroid nodules (which were more frequent
than thyroid cancer) were found to increase when increasing
thyroid radiation (Khokhryakov et al, 2002; Lyon et al, 2006;
Mushkacheva et al, 2006). The lack of significant dose response in
the Hanford studies could be due to low dose rate (Davis et al,
2004), but the results from the Marshall studies remain
unexplained (Takahashi et al, 2003). However, none of these
studies controlled for other risk factors for thyroid cancer. In fact,
most of the information on thyroid cancer risk after exposure to
131I comes from studies of the Chernobyl accident. The largest
case–control study in Belarus and Russian Federation (Cardis
et al, 2005) estimated ERR/Gy as varying between 4.5 (95% CI:
2.1–8.5) and 7.4 (3.1–16.3) for exposure before age 15 years,
depending on the model used. Another such study with 66 cases
and 132 controls (Kopecky et al, 2006), two geographical studies
(Jacob et al, 2006; Likhtarov et al, 2006) and one cohort study
(Tronko et al, 2006) including 13127 children from Ukraine found
compatible results: an ERR/Gy of 48.7 (94% CI: 4.8–1151), of 19
(95% CI: 11–27), of 8.0 (95% CI: 4.6–15) and of 5.3 (95% CI:
1.7–27.5), respectively. These estimates are in agreement with the
ERR/Gy of 7.7 (95% CI: 2.1–28.7) for external irradiation of
thyroid in a meta-analysis of seven studies (Ron et al, 1995) and
lower than, although compatible with, the ERR/Gy of 55 (95% CI:
 14 to 288) that we have observed. These differences may be
related to differences in latency period: 10 years on average after
Chernobyl vs 30 years in Polynesia, and in dose: higher in
Chernobyl than in Polynesia. The average latency period of thyroid
cancers after childhood irradiation ranges between 20 and 40 years
(Boice, 2006). Chernobyl studies have not yet had a long enough
follow-up to observe the full effects of thyroid irradiation.
Low doses may be more carcinogenic than predicted from
studies of higher doses. The median thyroid radiation dose was
much lower in the Russian Federation than in Belarus (39 vs
356mGy), and the ERRs/Gy were 32 (95% CI: 1.3–761) vs 5.1 (95%
CI: 2.9–8.9) (Cardis et al, 2005). In the other population-based
case–control study (Kopecky et al, 2006), the median radiation
dose received by controls was 16mGy, and the ERR/Gy was
49 (95% CI: 4.8–1151). Similarly, a recent update of the follow-up
of the Israeli cohort of 10834 children who received radio-
therapy for tinea capitis in the 1950s (average dose: 55mGy,
from 4.5–495mGy) showed an overall ERR/Gy of 20.2 (95% CI:
11.3–32.3) (Sadetzki et al, 2006).
In Chernobyl, risk was much higher in the population living in
iodine-deficient areas, who had not been given post-exposure
iodine (Cardis et al, 2005). This has been attributed to continuous
thyroid stimulation (Ron, 2007). However, this does not explain
the high, although non-significant, ERR/Gy observed in the French
Polynesian population, as this population is not diet deficient in
iodine. In addition, in Marshall studies, dietary iodine intake was
an individual risk factor, rather than a factor interacting with
radiation (Takahashi et al, 2003).
The interaction between the number of pregnancies and the
radiation exposure in childhood on thyroid cancer risk is a new
finding, no other study has included women with such a high
average number of pregnancies. As during the first trimester, the
foetus is dependent on maternal thyroxin and later on the direct
supply of maternal iodine for its own thyroxin production (Sack,
2003), maternal thyroid activity is increased during pregnancy.
Estrogens, which are elevated during pregnancy, could have a
function in the proliferation of malignant thyroid cells (Glinoer
et al, 1990; Manole et al, 2001). Repeated pregnancies could
increase the risk of thyroid cancer after childhood irradiation, by
revealing radiation-induced DNA damages, which would have
remained silent without pregnancies.
Nuclear site work was not associated with an increased risk of
thyroid cancer, which is not unexpected: as this is neither
increased by medical
131I administration (Dickman et al, 2003)
nor by external irradiation (Ron et al, 1995) in adulthood. In
addition, 89% of thyroid cancers in our study occurred in females
and few women worked at the nuclear sites.
We found that the mean thyroid dose to the thyroid received in
FP as a consequence of the atmospheric nuclear tests was low, that
thyroid cancer risk increased with increasing dose, but that as
these were based on a limited number of measurements, they are
uncertain and probably underestimated. The release of classified
material on the radiological situation in FP after the tests would
help in refining the dose estimates.
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